415 related articles for article (PubMed ID: 4906048)
1. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
Browne SG
Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
[No Abstract] [Full Text] [Related]
2. Combined clofazimine- and dapsone-resistant leprosy. A case report.
Kar HK; Bhatia VN; Harikrishnan S
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
[TBL] [Abstract][Full Text] [Related]
3. Secondary dapsone-resistant leprosy in Shanghai Municipality.
Ji BH; Chen JK; Zhang JL; Hou YH; Ni GX; Zhang RB
Lepr Rev; 1983 Sep; 54(3):197-202. PubMed ID: 6355724
[No Abstract] [Full Text] [Related]
4. Drug susceptibility testing of Mycobacterium leprae.
Baohong J
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):830-5. PubMed ID: 3325575
[No Abstract] [Full Text] [Related]
5. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
Levy L; Shepard CC; Fasal P
Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
[No Abstract] [Full Text] [Related]
6. Prevalence of drug resistance in Dharmapuri and A. Pallipatti areas of Tamil Nadu.
Sreevatsa ; Ramu G; Desikan KV
Indian J Lepr; 1985; 57(2):376-82. PubMed ID: 3908580
[TBL] [Abstract][Full Text] [Related]
7. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
Walker LL; Van Landingham RM; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and paraclinical aspects of secondary drug resistance to 4-4' diaminodiphenylsulfone in a population of leprosy patients in Bamako, Republic of Mali].
Baquillon G; Ferracci C; Diallo J; Saint-AndreƩ P; Pattyn SR
Acta Leprol; 1981; 85():40-52. PubMed ID: 6805234
[No Abstract] [Full Text] [Related]
9. Primary dapsone-resistant leprosy in Cebu, Philippines.
Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607
[TBL] [Abstract][Full Text] [Related]
10. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
[TBL] [Abstract][Full Text] [Related]
11. The clinical diagnosis of dapsone resistant leprosy.
Taylor PM
Lepr India; 1982 Jan; 54(1):117-22. PubMed ID: 7047897
[TBL] [Abstract][Full Text] [Related]
12. Some characteristics of the action of dapsone on multiplication of Mycobacterium leprae in the mouse.
Levy L; Peters JH
Lepr Rev; 1977 Dec; 48(4):237-45. PubMed ID: 400808
[No Abstract] [Full Text] [Related]
13. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.
Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852
[No Abstract] [Full Text] [Related]
15. Studies on dapsone-resistant Mycobacterium leprae in leprosy patients of Gudiyatham Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 2. A progress report.
Almeida JG; Christian M; Chacko CJ; Taylor PM; Fritschi EP
Lepr Rev; 1983 Sep; 54(3):185-91. PubMed ID: 6355722
[No Abstract] [Full Text] [Related]
16. Primary dapsone resistance in leprosy.
Vaishnavi C; Ganguly NK; Kumar B; Kaur S; Chakravarti RN
Indian J Lepr; 1985; 57(3):507-13. PubMed ID: 3913705
[TBL] [Abstract][Full Text] [Related]
17. Clofazimine-resistant M. leprae.
Levy L
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):137-40. PubMed ID: 3519801
[No Abstract] [Full Text] [Related]
18. Primary dapsone-resistant leprosy in San Francisco.
Gelber RH
Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067
[TBL] [Abstract][Full Text] [Related]
19. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
[No Abstract] [Full Text] [Related]
20. Characteristics of the multiplication of dapsone-resistant strains of Mycobacterium leprae in mice. Subcommittee on Clinical Trials of the C hemotherapy of Leprosy (THELEP) Scientific Working Group of UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
Lepr Rev; 1988 Mar; 59(1):5-10. PubMed ID: 3294541
[No Abstract] [Full Text] [Related]
[Next] [New Search]